These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16915552)

  • 41. First-episode psychosis after taking an extract of Hypericum perforatum (St John's Wort).
    Shimizu K; Nakamura M; Isse K; Nathan PJ
    Hum Psychopharmacol; 2004 Jun; 19(4):275-6. PubMed ID: 15181657
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
    Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
    Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse.
    Serdarevic N; Eckert GP; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S134-6. PubMed ID: 11518062
    [No Abstract]   [Full Text] [Related]  

  • 44. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [St. John's Wort for depression. 900 mg per day should an effective dose].
    MMW Fortschr Med; 2002 May; Suppl 2():87. PubMed ID: 12070867
    [No Abstract]   [Full Text] [Related]  

  • 46. Suspected withdrawal syndrome after cessation of St. John's wort.
    Dean AJ; Moses GM; Vernon JM
    Ann Pharmacother; 2003 Jan; 37(1):150. PubMed ID: 12503953
    [No Abstract]   [Full Text] [Related]  

  • 47. Kava update: a European perspective.
    Ernst E
    N Z Med J; 2004 Nov; 117(1205):U1143. PubMed ID: 15570327
    [No Abstract]   [Full Text] [Related]  

  • 48. Delayed-type hypersensitivity reaction to St. John's wort extract confirmed by patch testing.
    O'Hagan T; Bisconti I; Leck C; Billahalli T; Barnett S; Rajakulasingam K; Watts TJ
    Contact Dermatitis; 2022 Oct; 87(4):381-383. PubMed ID: 35681252
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of St John's wort on the pharmacokinetics of fexofenadine.
    Wang Z; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2002 Jun; 71(6):414-20. PubMed ID: 12087344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. St. John's wort for the treatment of psychiatric disorders.
    Sarris J
    Psychiatr Clin North Am; 2013 Mar; 36(1):65-72. PubMed ID: 23538077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kava hepatotoxicity: a European view.
    Teschke R; Schwarzenboeck A; Akinci A
    N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. St. John's Wort linked to kidney rejection.
    Nephrol News Issues; 2000 Nov; 14(12):66. PubMed ID: 11933399
    [No Abstract]   [Full Text] [Related]  

  • 54. St. John's Wort extract: efficacy for menopausal symptoms of psychological origin.
    Grube B; Walper A; Wheatley D
    Adv Ther; 1999; 16(4):177-86. PubMed ID: 10623319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Herbal Supplements: Precautions and Safe Use.
    Williams CT
    Nurs Clin North Am; 2021 Mar; 56(1):1-21. PubMed ID: 33549278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
    Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
    Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.
    Teschke R; Schwarzenboeck A; Hennermann KH
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1182-93. PubMed ID: 18989142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.